Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.
Sort By: Relevancy | Date | Type
Displaying items 37-48 of 96
» View wsbtradio.com items only
    Jan 5, 2013 |Column| Los Angeles Times
  1. Corporations and execs need penalties that hurt

    If you're concerned about corporate crime, 2012 looked like a pretty successful year for the good guys.
    If you're concerned about corporate crime, 2012 looked like a pretty successful year for the good guys. The Thousand Oaks biotech giant Amgen paid $762 million in fines and penalties and pleaded guilty to a federal charge related to illegal marketing of...

    Tags: Countrywide Financial Corp., Michael Mukasey, Abbott Laboratories, GlaxoSmithKline PLC, Financial Markets

  2. Aug 20, 2012 |Story| Chicago Tribune
  3. CEO of Strategic Thinking Institute grasped value while watching operation

    A dozen managers sat around a rectangular table at the Wit hotel in the Loop, their attention fixed on a man in an Armani suit standing in the front of the room.
    Special to the Tribune
    A dozen managers sat around a rectangular table at the Wit hotel in the Loop, their attention fixed on a man in an Armani suit standing in the front of the room.    They waited quietly, the CTA Red Line train periodically rumbling by, until the tall,...

    Tags: Companies and Corporations, Book, Abbott Laboratories, Sam Phillips, Hospitals and Clinics

  4. Aug 22, 2012 | Los Angeles Times
  5. Novartis patent case in India seen as crucial for generic drugs

    World Now
    The Indian Supreme Court is slated Wednesday to take up a case that aid agencies warn could have sweeping effects on medicine for the global poor, the culmination of a lengthy legal battle between a Swiss drug company and a country known as a mecca for...
  6. Aug 22, 2012 | Los Angeles Times
  7. Greek leader pleads for more time to implement reforms

    World Now
    Greek Prime Minister Antonis Samaras launched a high-gear diplomatic offensive aimed at buying his country more time to implement reforms demanded by increasingly impatient European creditors....
  8. Nov 16, 2012 |Story| Chicago Tribune
  9. U.S. sues doctor known for prescribing risky drug clozapine

    Federal authorities on Thursday sued a controversial Chicago psychiatrist, accusing him of pocketing kickbacks from drug companies and committing a massive fraud as he prescribed antipsychotic medication to thousands of mentally ill patients in area nursing homes.
    Federal authorities on Thursday sued a controversial Chicago psychiatrist, accusing him of pocketing kickbacks from drug companies and committing a massive fraud as he prescribed antipsychotic medication to thousands of mentally ill patients in area...

    Tags: Arts and Culture, Culture, Long Term Care, Medicaid, Chemical Industry

  10. Oct 16, 2012 |Story| Chicago Tribune
  11. How to apply false eyelashes

    Applying false eyelashes is becoming as routine as hair-washing for some women. And not just those whose last name is Kardashian. "They can look really fresh when you wear them with minimal makeup during the day," says Andrea Pomerantz Lustig, Glamour's beauty editor and author of "How to Look Expensive" (Gotham Books). Here's Lustig's technique.
    Applying false eyelashes is becoming as routine as hair-washing for some women. And not just those whose last name is Kardashian. "They can look really fresh when you wear them with minimal makeup during the day," says Andrea Pomerantz Lustig, Glamour's...

    Tags: Drugstore.com Inc., Revlon Incorporated

  12. Sep 13, 2012 |Story| Los Angeles Times
  13. Fighting diseases with genetic therapy

    Genes make us who we are — in sickness and in health. We get our genetic makeup from our parents, of course, but in the future, we might be getting genes from our doctors too. Imagine your doctor promising to cure your cancer or heart disease by prescribing some new snippets of DNA.
    Genes make us who we are — in sickness and in health. We get our genetic makeup from our parents, of course, but in the future, we might be getting genes from our doctors too. Imagine your doctor promising to cure your cancer or heart disease by...

    Tags: Medical Research, Arteriosclerotic Vascular Disease, Genetic Engineering, Colleges and Universities, Chemotherapy

  14. Jun 15, 2012 |Story| Aberdeen News
  15. Novartis introduces Cattle Vaccine Literature Library app for iPads

    Greensboro, N.C. - Novartis Animal Health announces the release of a new app designed specifically for U.S. cattle veterinarians and producers. The Novartis Cattle Vaccine Literature Library app provides fast and convenient access to over 50 product...

    Tags: Arts and Culture, Marketing, Computer Hardware, Drugs and Medicines, Vaccines

  16. Jun 19, 2012 |Story| Hartford Courant
  17. Alexion: Profile From The Company's 2012 Annual Report

    Overview Alexion is a biopharmaceutical company focused on serving patients with severe and ultra-rare disorders through the innovation, development and commercialization of life-transforming therapeutic products. Our marketed product Soliris®...

    Tags: Culture, Charity, Companies and Corporations, Kidney Disease, Blood

  18. Mar 19, 2012 |Story| South Florida Sun-Sentinel
  19. Rare diseases affect millions of American families

    One in 10 Americans is currently affected by a rare disease. For these people, getting properly diagnosed and treated can be a challenge.
    www.southfloridaparenting.com
    One in 10 Americans is currently affected by a rare disease. For these people, getting properly diagnosed and treated can be a challenge. Studies have shown it often takes five years or longer to receive an accurate diagnosis of a rare disease, according...

    Tags: Skin Rash, Drugs and Medicines, Genes and Chromosomes, Health, National Institutes of Health

  20. Jan 9, 2012 |Story| WPMT-LTV
  21. Novartis Recalls Popular OTC Medication

    Novartis Consumer Health (NCH) is voluntarily recalling all lots of select bottle sizes of Excedrin® and NoDoz® Alertness Aid products with expiry dates of December 20, 2014 or earlier as well as Bufferin® and Gas-X® Prevention® products with expiry dates of December 20, 2013 or earlier, in the United States.
    Novartis Consumer Health (NCH) is voluntarily recalling all lots of select bottle sizes of Excedrin® and NoDoz® Alertness Aid products with expiry dates of December 20, 2014 or earlier as well as Bufferin® and Gas-X® Prevention® products with expiry dates...

    Tags: Product Recalls, Consumers

  22. Jan 10, 2012 |Story| WPIX-LTV
  23. Excedrin, Bufferin Recalled Due to Broken, Mislabeled Pills

    Pharmaceutical company Novartis on Sunday voluntarily recalled a number of over-the-counter drugs -- including certain bottles of Excedrin and Bufferin -- due to complaints about mislabeled and broken pills.
    Pharmaceutical company Novartis on Sunday voluntarily recalled a number of over-the-counter drugs -- including certain bottles of Excedrin and Bufferin -- due to complaints about mislabeled and broken pills. The Switzerland-based company said on its...

    Tags: Companies and Corporations, Drugs and Medicines, Chemicals, Product Recalls, Drugs and Medicines

< Previous1 2 3  4  5 6 7 8Next >
Original site for Novartis AG topic gallery.
Loading...
 
 

Date:

Credit:

User-submitted

Tags:

Rate:
Sending...

E-mail this photo

Error: malformed email address(es)
Both "from" and "recipient" email fields are required.

Recipient E-mail Addresses

(up to 3, separated by commas) Send me a copy.

From:

e-mail | buy this photo | link to photo
Novartis AG Photos
Novartis headquarters in Basel, Switzerland.
(April 26, 2013)
Novartis headquarters
Barbara Kittridge has been appointed chief marketing of...
(January 10, 2013)
Barbara Kittridge, chief marketing officer, Cardinal Path Inc.
Steve Auten has joined Cozen O'Connor as a member of th...
(September 5, 2012)
Steve Auten, partner, Cozen O'Connor